Results 251 to 260 of about 283,224 (387)

Phase 2 study of combination SPI-1620 with docetaxel as second-line advanced biliary tract cancer treatment [PDF]

open access: yes, 2017
A Rai   +30 more
core   +3 more sources

A comparison by mismatch repair status of real‐world characteristics and outcomes in patients with stage II/III rectal cancer in the Netherlands

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Mismatch repair deficiency (dMMR) in rectal cancer is rare, and knowledge about tumor biological behavior, response to treatment, and clinical outcomes in this subset of patients is limited. This nationwide cohort study including 182 patients with dMMR rectal cancer found that they were younger and had more poorly differentiated tumors ...
Renee A. Lunenberg   +14 more
wiley   +1 more source

Prospective validation of the modified metastatic colorectal cancer score (mCCS) in >600 patients with RAS‐wild‐type metastatic colorectal cancer treated with first‐line panitumumab plus FOLFIRI/FOLFOX: Final results of the non‐interventional study VALIDATE

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Prognostic assessment in metastatic colorectal cancer (mCRC), which is currently based on scores derived from clinical trials, requires refinement to enhance treatment outcomes and quality of care. In this study, the authors evaluated real‐world data from the German tumor registry to prospectively validate a modified mCRC prognostic score ...
Karin Potthoff   +19 more
wiley   +1 more source

Advanced-stage colorectal cancer in the context of coronavirus disease-19, highlighting socioeconomic disparities and outcomes: a case report. [PDF]

open access: yesJ Med Case Rep
Brim H   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy